Evidence map›Paper›PMID 20339349›Full record

ArticleThe EMBO journal2010

A functional human Poly(A) site requires only a potent DSE and an A-rich upstream sequence.

Nuno Miguel Nunes, Wencheng Li, Bin Tian, André Furger

Open access · greenAbstract read
In one paragraph

Article in The EMBO journal, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 91 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Adenine base editing of theMolecular therapy. Nucleic acids · 2021
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Nuno Miguel NunesDepartment of Biochemistry, University of Oxford, Oxford, UK.
Wencheng Li
Bin Tian
André Furger
Rutgers New Jersey Medical SchoolUniversity of Oxford · GB

Funding

Regulation of Alternative Cleavage and PolyadenylationR01GM084089 · NIGMS · WISTAR INSTITUTE · PI TIAN, BIN · 2008 to 2023
$6.7M
NIGMS NIH HHS R01 GM084089Wellcome Trust 081083/Z/06/Z
6 · The paper itself

Abstract

We have analysed the sequences required for cleavage and polyadenylation in the intronless melanocortin 4 receptor (MC4R) pre-mRNA. Unlike other intronless genes, 3'end processing of the MC4R primary transcript is independent of any auxiliary sequence elements and only requires the core poly(A) sequences. Mutation of the AUUAAA hexamer had little effect on MC4R 3'end processing but small changes in the short DSE severely reduced cleavage efficiency. The MC4R poly(A) site requires only the DSE and an A-rich upstream sequence to direct efficient cleavage and polyadenylation. Our observation may be highly relevant for the understanding of how human noncanonical poly(A) sites are recognised. This is supported by a genome-wide analysis of over 10 000 poly(A) sites where we show that many human noncanonical poly(A) signals contain A-rich upstream sequences and tend to have a higher frequency of U and GU nucleotides in their DSE compared with canonical poly(A) signals. The importance of A-rich elements for noncanonical poly(A) site recognition was confirmed by mutational analysis of the human JUNB gene, which contains an A-rich noncanonical poly(A) signal.

Indexed as

3' Untranslated Regions3' Flanking RegionAdenosineAntigens, NeoplasmBase SequenceCell LineDNA-Binding ProteinsHumansMolecular Sequence DataMutationNeoplasm ProteinsPoly AProto-Oncogene Proteins c-junReceptor, Melanocortin, Type 4RNA PrecursorsUridine3' Untranslated RegionsAdenosineAntigens, NeoplasmDNA-Binding ProteinsDSE protein, humanNeoplasm ProteinsPoly AProto-Oncogene Proteins c-junReceptor, Melanocortin, Type 4RNA PrecursorsUridine

Identifiers

PMID20339349
PMCPMC2876958
OpenAlexW2042783076

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.